Who are Combined Acetaminophen and Ibuprofen's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/combined-acetaminophen-and-ibuprofen.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Combined Acetaminophen and Ibuprofen — Competitive Intelligence Brief

Combined Acetaminophen and Ibuprofen (Combined Acetaminophen and Ibuprofen) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Fixed-dose combination analgesic/antipyretic. Area: Pain Management.

phase 3 Fixed-dose combination analgesic/antipyretic COX-1, COX-2 (ibuprofen component); unclear central target (acetaminophen component) Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Combined Acetaminophen and Ibuprofen (Combined Acetaminophen and Ibuprofen) — Washington University School of Medicine. This combination drug reduces pain and fever by inhibiting cyclooxygenase enzymes (via ibuprofen) and modulating central pain pathways (via acetaminophen) simultaneously.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Combined Acetaminophen and Ibuprofen TARGET	Combined Acetaminophen and Ibuprofen	Washington University School of Medicine	phase 3	Fixed-dose combination analgesic/antipyretic	COX-1, COX-2 (ibuprofen component); unclear central target (acetaminophen component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Fixed-dose combination analgesic/antipyretic class)

Washington University School of Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Combined Acetaminophen and Ibuprofen — Competitive Intelligence Brief. https://druglandscape.com/ci/combined-acetaminophen-and-ibuprofen. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab